Page last updated: 2024-09-04
yttria and ceruletide
yttria has been researched along with ceruletide in 1 studies
Compound Research Comparison
| Studies (yttria) | Trials (yttria) | Recent Studies (post-2010) (yttria) | Studies (ceruletide) | Trials (ceruletide) | Recent Studies (post-2010) (ceruletide) |
|---|---|---|---|---|---|
| 327 | 1 | 234 | 3,002 | 91 | 645 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Allawadhi, P; Anchi, P; Godugu, C; Khurana, A; Kumar, V; Packirisamy, G; Sayed, N | 1 |
Other Studies
1 other study(ies) available for yttria and ceruletide
| Article | Year |
|---|---|
Yttrium oxide nanoparticles reduce the severity of acute pancreatitis caused by cerulein hyperstimulation.
Topics: Acute Disease; Animals; Antioxidants; Biomarkers; Ceruletide; Endoplasmic Reticulum Stress; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Macrophages; Male; Membrane Potential, Mitochondrial; Mice; Nanoparticles; Neutrophils; Nitrosation; Oxidation-Reduction; Oxidative Stress; Pancreas; Pancreatitis; RAW 264.7 Cells; Reactive Oxygen Species; Severity of Illness Index; Transcription Factor RelA; Yttrium | 2019 |